Follow
Translational Oncology
Translational Oncology involves moving scientific discoveries made in a laboratory setting into clinical applications that enhance treatment efficacy and outcomes for cancer patients. Translational Oncology approaches include pre-clinical research, which can be done in an in vivo, in vitro, or ex vivo setting, before validating the laboratory findings with a clinical trial.
-
JUN 14, 2016 | 2:53 PM
Testcast...MAY 12, 2016 | 12:00 PM
In order to realize the benefits of personalized cancer therapy, increasing demands are placed upon clinical laboratories to provide timely, comprehensive, clinically actionable, and analytic...MAY 04, 2016 | 9:00 AM
Self-assembling protein microarrays arrays can be used to study protein-protein interactions, protein-drug interactions, search for enzyme substrates, and as tools to search for disease bioma...FEB 24, 2016 | 1:00 PM
Precision medicine requires understanding the mechanistic basis of complex disorders, and to precisely manipulate these mechanisms to better human health. This is partly enabled by the recent...FEB 24, 2016 | 12:00 PM
The advent of the microarray technology in 2000 has paved the way for advanced translational research methods that use molecular markers such as microRNA, proteins, metabolites and copy numbe...FEB 24, 2016 | 9:00 AM
On January 20, 2015, President Obama announced the Precision Medicine Initiative® (PMI) (link is external) in his State of the Union address. Through advances in research, technology and...FEB 24, 2016 | 7:00 AM
A number of recently publications have heralded the advent of Precision Medicine in Oncology, where next generation sequencing technology, other ’omics technologies, serial biopsies, so...FEB 04, 2016 | 10:30 AM
The environment has been found to be a major contributor to data variability and many aspects of the laboratory environment are stressful to rodents and do not accurately reflect the human ex...FEB 04, 2016 | 9:00 AM
The National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) is leading an initiative to improve the design and reporting of animal research. The ARRIVE (A...FEB 04, 2016 | 6:00 AM
A number of elements come into the mix when trying to optimise experimental design. Among these are having clear objectives, setting up valid comparisons, knowing how to avoid bias during the...Speaker: Derek Fry OBE, MA, D Phil, MB BCh , Rob de Vries, PhDPresented at: Laboratory Animal Sciences Virtual Event Series 2016
FEB 04, 2016 | 6:00 AM
Public, legal & ethical acceptability of animal research not only warrants respect for animal welfare & the 3Rs, but also that the perceived benefits can outweigh the pain, discomfort...FEB 03, 2016 | 3:00 PM
Understanding systematic biases in primary research are important for appropriate interpretation of research and recognizing features of reproducible research. Systematic biases arise from th...Speaker: Annette O'Connor, BVSc, MVSc, DVSc, FACVScPresented at: Laboratory Animal Sciences Virtual Event Series 2016
FEB 03, 2016 | 3:00 PM
Animal models have provided an important tool to help make the decision to take potential therapies from preclinical studies to humans. In the past several years, the strong reliance of the p...FEB 03, 2016 | 1:30 PM
Surgerized animals play a crucial role in preclinical research aimed at drug and medical device discovery into treatments for humans. When implementing new in-house surgical models to perform...Speaker: Szczepan Baran, VMD, MSPresented at: Laboratory Animal Sciences Virtual Event Series 2016
FEB 03, 2016 | 12:00 PM
Animal studies still play a crucial role in research aimed at improving human health care. When performing animal studies, the results and their interpretation are not always straightforward....Speaker: Carlijn Hooijmans, PhDPresented at: Laboratory Animal Sciences Virtual Event Series 2016
FEB 03, 2016 | 9:00 AM
Translational failure in biomedicine has led to much soul-searching about the causes for this. Amongst many others (misunderstanding of statistical tests, vibration of effects, flexibility in...Speaker: Malcolm Macleod BSc(Hons) MBChB PhD FRCP EdPresented at: Laboratory Animal Sciences Virtual Event Series 2016
FEB 03, 2016 | 6:00 AM
Why did we change focus from the 3Rs to Systematic Reviews? Questionnaires on the 3Rs have revealed that the 3R search gets no high priority and the 3R search process is never included in fun...Speaker: Merel Ritskes-Hoitinga, DVM, PhD, Animal Welfare Officer, Dipl ECLAMPresented at: Laboratory Animal Sciences Virtual Event Series 2016
JAN 15, 2016 | 4:00 AM
DATE: January 15, 2016 TIME: 7am EST, 12pm UK, 1pm CET With an increasing number of biomarkers and, often, limited availability of biopsy material, there is a growing need for multiplexed...Speaker: Matthew Silver, PhDSponsored By: Cell Signaling Technology, Cell Signaling TechnologyNOV 12, 2015 | 1:30 PM
Currently, next-generation sequencing is not only being used for basic discovery research but also in clinical settings for translational biomarker profiling and clinical research studies inc...Speaker: Jennifer Fostel, MSNOV 12, 2015 | 10:30 AM
Basic research in Proteomics has led to new understanding of proteins’ contributions to health and disease, and has also driven the advancement of powerful analytical technologies used...Speaker: Doug Jeffery, PhDOCT 01, 2015 | 7:30 AM
Melanoma, a cancer of pigment-producing cells, accounts for nearly 200,000 new cases of cancer reported each year worldwide. It is the deadliest skin cancer. Alarmingly, in the U.S., the inci...Speaker: Louise Perkins, PhDSEP 30, 2015 | 10:30 AM
The management of prostate cancer (PCa) continues to evolve and does so at a rapid rate. Research and technological developments continue to refine our definitions and management of this comp...Speaker: Rajan Gupta, MD , Thomas Polascik, MD , Stacy Loeb, MDSEP 16, 2015 | 9:00 AM
Learning Objectives for this presentation - (1) Understand how human genetics can contribute to drug discovery and development. (2) Understand the role of biomarkers and clinical proof-...Speaker: Robert PlengeJUL 22, 2015 | 9:00 AM
DATE: July 22, 2015TIME: 9:00AM PT, 12:00PM ETHuman induced pluripotent stem cells (iPSCs) bring human biology into pre-clinical aspects of drug discovery. iPSC-derived cardiomyocytes have em...Speaker: Blake Anson, PhD , Mathew Brock, PhDSponsored By: Cellular Dynamics, Cellular Dynamics
JUN 14, 2016 | 2:53 PM
Testcast...
MAY 12, 2016 | 12:00 PM
In order to realize the benefits of personalized cancer therapy, increasing demands are placed upon clinical laboratories to provide timely, comprehensive, clinically actionable, and analytic...
MAY 04, 2016 | 9:00 AM
Self-assembling protein microarrays arrays can be used to study protein-protein interactions, protein-drug interactions, search for enzyme substrates, and as tools to search for disease bioma...
FEB 24, 2016 | 1:00 PM
Precision medicine requires understanding the mechanistic basis of complex disorders, and to precisely manipulate these mechanisms to better human health. This is partly enabled by the recent...
FEB 24, 2016 | 12:00 PM
The advent of the microarray technology in 2000 has paved the way for advanced translational research methods that use molecular markers such as microRNA, proteins, metabolites and copy numbe...
FEB 24, 2016 | 9:00 AM
On January 20, 2015, President Obama announced the Precision Medicine Initiative® (PMI) (link is external) in his State of the Union address. Through advances in research, technology and...
FEB 24, 2016 | 7:00 AM
A number of recently publications have heralded the advent of Precision Medicine in Oncology, where next generation sequencing technology, other ’omics technologies, serial biopsies, so...
FEB 04, 2016 | 10:30 AM
The environment has been found to be a major contributor to data variability and many aspects of the laboratory environment are stressful to rodents and do not accurately reflect the human ex...
FEB 04, 2016 | 9:00 AM
The National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) is leading an initiative to improve the design and reporting of animal research. The ARRIVE (A...
FEB 04, 2016 | 6:00 AM
A number of elements come into the mix when trying to optimise experimental design. Among these are having clear objectives, setting up valid comparisons, knowing how to avoid bias during the...
Speaker:
Derek Fry OBE, MA, D Phil, MB BCh
, Rob de Vries, PhD
Presented at: Laboratory Animal Sciences Virtual Event Series 2016
FEB 04, 2016 | 6:00 AM
Public, legal & ethical acceptability of animal research not only warrants respect for animal welfare & the 3Rs, but also that the perceived benefits can outweigh the pain, discomfort...
FEB 03, 2016 | 3:00 PM
Understanding systematic biases in primary research are important for appropriate interpretation of research and recognizing features of reproducible research. Systematic biases arise from th...
Speaker:
Annette O'Connor, BVSc, MVSc, DVSc, FACVSc
Presented at: Laboratory Animal Sciences Virtual Event Series 2016
FEB 03, 2016 | 3:00 PM
Animal models have provided an important tool to help make the decision to take potential therapies from preclinical studies to humans. In the past several years, the strong reliance of the p...
FEB 03, 2016 | 1:30 PM
Surgerized animals play a crucial role in preclinical research aimed at drug and medical device discovery into treatments for humans. When implementing new in-house surgical models to perform...
Speaker:
Szczepan Baran, VMD, MS
Presented at: Laboratory Animal Sciences Virtual Event Series 2016
FEB 03, 2016 | 12:00 PM
Animal studies still play a crucial role in research aimed at improving human health care. When performing animal studies, the results and their interpretation are not always straightforward....
Speaker:
Carlijn Hooijmans, PhD
Presented at: Laboratory Animal Sciences Virtual Event Series 2016
FEB 03, 2016 | 9:00 AM
Translational failure in biomedicine has led to much soul-searching about the causes for this. Amongst many others (misunderstanding of statistical tests, vibration of effects, flexibility in...
Speaker:
Malcolm Macleod BSc(Hons) MBChB PhD FRCP Ed
Presented at: Laboratory Animal Sciences Virtual Event Series 2016
FEB 03, 2016 | 6:00 AM
Why did we change focus from the 3Rs to Systematic Reviews? Questionnaires on the 3Rs have revealed that the 3R search gets no high priority and the 3R search process is never included in fun...
Speaker:
Merel Ritskes-Hoitinga, DVM, PhD, Animal Welfare Officer, Dipl ECLAM
Presented at: Laboratory Animal Sciences Virtual Event Series 2016
JAN 15, 2016 | 4:00 AM
DATE: January 15, 2016
TIME: 7am EST, 12pm UK, 1pm CET
With an increasing number of biomarkers and, often, limited availability of biopsy material, there is a growing need for multiplexed...
Speaker:
Matthew Silver, PhD
Sponsored By: Cell Signaling Technology,
Cell Signaling Technology
NOV 12, 2015 | 1:30 PM
Currently, next-generation sequencing is not only being used for basic discovery research but also in clinical settings for translational biomarker profiling and clinical research studies inc...
Speaker:
Jennifer Fostel, MS
NOV 12, 2015 | 10:30 AM
Basic research in Proteomics has led to new understanding of proteins’ contributions to health and disease, and has also driven the advancement of powerful analytical technologies used...
Speaker:
Doug Jeffery, PhD
OCT 01, 2015 | 7:30 AM
Melanoma, a cancer of pigment-producing cells, accounts for nearly 200,000 new cases of cancer reported each year worldwide. It is the deadliest skin cancer. Alarmingly, in the U.S., the inci...
Speaker:
Louise Perkins, PhD
SEP 30, 2015 | 10:30 AM
The management of prostate cancer (PCa) continues to evolve and does so at a rapid rate. Research and technological developments continue to refine our definitions and management of this comp...
Speaker:
Rajan Gupta, MD
, Thomas Polascik, MD
, Stacy Loeb, MD
SEP 16, 2015 | 9:00 AM
Learning Objectives for this presentation -
(1) Understand how human genetics can contribute to drug discovery and development.
(2) Understand the role of biomarkers and clinical proof-...
Speaker:
Robert Plenge
JUL 22, 2015 | 9:00 AM
DATE: July 22, 2015TIME: 9:00AM PT, 12:00PM ETHuman induced pluripotent stem cells (iPSCs) bring human biology into pre-clinical aspects of drug discovery. iPSC-derived cardiomyocytes have em...
Speaker:
Blake Anson, PhD
, Mathew Brock, PhD
Sponsored By: Cellular Dynamics,
Cellular Dynamics